147 related articles for article (PubMed ID: 24319959)
1. [Analysis of 11 cases of mycoplasma pneumoniae infection combined with Kawasaki disease].
Zhu Q; Guo JC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Jun; 27(3):207-9. PubMed ID: 24319959
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 12 cases of Kawasaki disease complicated by Mycoplasma pneumoniae pneumonia].
Zhang YF; Zhao ZQ
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):603-4. PubMed ID: 18082052
[No Abstract] [Full Text] [Related]
3. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
[TBL] [Abstract][Full Text] [Related]
4. [Kawasaki disease and Mycoplasma pneumoniae infection].
Chemli J; Hassayoun S; Ketata S; Ajmi H; Ayeche H; Zouari N; Abroug S; Boujaafar N; Harbi A
Med Mal Infect; 2010 Dec; 40(12):717-9. PubMed ID: 20650584
[No Abstract] [Full Text] [Related]
5. [Kawasaki syndrome and Mycoplasma pneumoniae infection].
Merlin E; Al Fatuhi H; Crost P
Arch Pediatr; 2004 Aug; 11(8):972-3. PubMed ID: 15288092
[No Abstract] [Full Text] [Related]
6. Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children: a 2-year experience.
Lu YJ; Chen TH; Lin LH; Shen CM; Huang CH
J Microbiol Immunol Infect; 2008 Aug; 41(4):307-10. PubMed ID: 18787737
[TBL] [Abstract][Full Text] [Related]
7. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.
Shan LS; Liu X; Kang XY; Wang F; Han XH; Shang YX
World J Pediatr; 2017 Aug; 13(4):321-327. PubMed ID: 28130749
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of recurrent Kawasaki disease in 20 children].
Zou LX; Gong FQ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):617-9. PubMed ID: 18947484
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia: A retrospective study.
Lan Y; Li S; Yang D; Zhou J; Wang Y; Wang J; Xu Y; Chen Z
Medicine (Baltimore); 2020 May; 99(19):e19987. PubMed ID: 32384451
[TBL] [Abstract][Full Text] [Related]
10. Mycoplasma pneumoniae: a possible trigger of kawasaki disease or a mere coincidental association? Report of the first four Italian cases.
Vitale EA; La Torre F; Calcagno G; Infricciori G; Fede C; Conti G; Chimenz R; Falcini F
Minerva Pediatr; 2010 Dec; 62(6):605-7. PubMed ID: 21042274
[TBL] [Abstract][Full Text] [Related]
11. Kawasaki disease associated with Mycoplasma pneumoniae.
Tang Y; Yan W; Sun L; Huang J; Qian W; Hou M; Lv H
Ital J Pediatr; 2016 Sep; 42(1):83. PubMed ID: 27609267
[TBL] [Abstract][Full Text] [Related]
12. Infections and Kawasaki disease: implications for coronary artery outcome.
Benseler SM; McCrindle BW; Silverman ED; Tyrrell PN; Wong J; Yeung RS
Pediatrics; 2005 Dec; 116(6):e760-6. PubMed ID: 16322132
[TBL] [Abstract][Full Text] [Related]
13. Mycoplasma pneumonia in young children, 2-5 years of age.
Bunnag T; Lochindarat S; Srisan P; Jetanachai P
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S124-7. PubMed ID: 19253507
[TBL] [Abstract][Full Text] [Related]
14. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
[TBL] [Abstract][Full Text] [Related]
15. Atypical and complicated Kawasaki disease in infants. Do we need criteria?
Joffe A; Kabani A; Jadavji T
West J Med; 1995 Apr; 162(4):322-7. PubMed ID: 7747497
[TBL] [Abstract][Full Text] [Related]
16. [Kawasaki disease. A report of 50 cases].
González Pascual E; Villanueva Lamas J; Ros Viladoms J; Pons Odena M; Ruiz García-Diego S
An Esp Pediatr; 1999 Jan; 50(1):39-43. PubMed ID: 10083641
[TBL] [Abstract][Full Text] [Related]
17. [Chest CT features and outcome of necrotizing pneumonia caused by Mycoplasma pneumoniae in children (report of 30 cases)].
Li SR; Mu JH; Chang L; Yan YC; Yuan XY; Chen HZ
Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):211-5. PubMed ID: 23751584
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
Patel A; Holman RC; Callinan LS; Sreenivasan N; Schonberger LB; Fischer TK; Belay ED
Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838
[TBL] [Abstract][Full Text] [Related]
20. Hair loss as a sign of Kawasaki disease.
Nabavizadeh SH; Safari M; Amin R
Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):199-200. PubMed ID: 17237574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
